AI-generated summary
The authors reviewed 72 original clinical studies of intense pulsed light (IPL) for eyelid inflammatory conditions, mostly meibomian gland dysfunction. They report that dry eye symptoms, tear break-up time and meibomian gland structure or function improved in most patients. They conclude the evidence suggests IPL is an effective option for most patients with meibomian gland dysfunction, but more clinical evidence is needed for other indications.
- Studies included
- 72
- Who or what was studied
- Patients with eyelid inflammatory diseases, including meibomian gland dysfunction, blepharitis and ocular rosacea
- Limits stated in the abstract
- The abstract states that more clinical evidence is needed for indications other than meibomian gland dysfunction.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Reactive oxygen species, Photobiomodulation, Inflammation, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.